Why Bay Area's XOMA Surged 700% in 2017 by Not Making Drugs Post author:Sam Post published:January 25, 2018 Post category:BioPharma The company burned through $1.2B and never brought a drug to market in its 37 years. Source: BioSpace You Might Also Like Juniper Pharma Reports Second Quarter 2017 Financial And Operating Results August 3, 2017 Atossa Genetics Announces First Quarter 2017 Financial Results And Provides Company Update May 15, 2017 Counsyl Celebrates Anniversary With $80M Funding Round November 6, 2017
Atossa Genetics Announces First Quarter 2017 Financial Results And Provides Company Update May 15, 2017
